AlphaFold predicted structure
BIN1 · O00499

Mean pLDDT
66.7/ 100
Low
593 residues
Confidence breakdown
- Very high(≥ 90)36%
- Confident(70–90)18%
- Low(50–70)5%
- Very low(< 50)41%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
bridging integrator 1
Annotations refreshed 1 month ago.
Diagnostic Grade (Green)
Congenital myopathy
BIALLELIC, autosomal or pseudoautosomalDDG2P
BIALLELIC, autosomal or pseudoautosomalFetal anomalies
BIALLELIC, autosomal or pseudoautosomalArthrogryposis
BIALLELIC, autosomal or pseudoautosomalIntellectual disability
BIALLELIC, autosomal or pseudoautosomalmyopathy, centronuclear, 2
autosomal recessive centronuclear myopathy
Alzheimer disease
autosomal dominant centronuclear myopathy
centronuclear myopathy
dementia
neurodegenerative disease
Abnormality of the skeletal system
Lewy body dementia
memory impairment
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Myc box-dependent-interacting protein 1
Is a key player in the control of plasma membrane curvature, membrane shaping and membrane remodeling. Required in muscle cells for the formation of T-tubules, tubular invaginations of the plasma membrane that function in depolarization-contraction coupling (PubMed:24755653). Is a negative regulator of endocytosis (By similarity). Is also involved in the regulation of intracellular vesicles sorting, modulation of BACE1 trafficking and the control of amyloid-beta production (PubMed:27179792). In neuronal circuits, endocytosis regulation may influence the internalization of PHF-tau aggregates (By similarity). May be involved in the regulation of MYC activity and the control cell proliferation (PubMed:8782822). Has actin bundling activity and stabilizes actin filaments against depolymerization in vitro (PubMed:28893863)
BIN1 · O00499

Mean pLDDT
66.7/ 100
Low
593 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0